Arzum shareholders explore sale of majority stake; shares surge

Shareholders controlling over 51% of Arzum's capital have decided to enter talks to sell their stakes, potentially partially or fully. The stock jumped nearly 10% to the exchange limit of 3.25 lira on the Istanbul bourse after the announcement. The company did not disclose which shareholders are involved, potential buyers, or any timeline for the discussions, leaving execution risk and valuation outcomes uncertain.

Analysis

This is a classic small-cap control-event: acquirers with strategic overlap (regional white‑goods manufacturers, private equity funds seeking platform plays) win by consolidating SKUs, backend logistics and procurement to extract 200–400bps margin improvement within 12–24 months. For suppliers and component makers, a takeover that centralizes purchasing can compress their margins short term but create a larger, more stable anchor customer that reduces working capital volatility over 2–3 years.

Primary risks are execution and financing: due diligence can reveal working‑capital holes or contingent liabilities that blow out assumed multiples, and a buyer financing gap can turn a premium bid into a protracted renegotiation — expect deal/no‑deal resolution within 1–6 months, with regulatory/antitrust and FX volatility as wildcards. Market microstructure matters: low‑float EM situations tend to gap violently on rumor and on announced terms, creating both outsized short‑term P&L swings and slippage risk for large orders.

The consensual framing — “event = cashing out at a control premium” — misses two second‑order outcomes: (1) if a strategic consolidator wins, nearby competitors could face price pressure as the acquirer deploys scale benefits across channels within 6–12 months; (2) if talks break down, the controlling holders may instead pursue minority asset sales or dividend recapitalization, which caps upside but increases near‑term cash yield. Both paths create distinct entry windows for different instruments (equity vs credit-like positions).

Key Decisions for Investors

• Event‑driven long ARZUM (equity): size at 3–5% position of regional small‑cap event portfolio on confirmation of an LOI/SPA. Target a 25–40% uplift (typical EM control premium), stop at 10–12% absolute downside or immediately on announcement of failed talks. Timeframe: 1–6 months. Expect high slippage; use limit orders and tranche execution.
• Hedge by pair: Long ARZUM / Short BIST‑100 ETF (or local large‑cap industrial like ARCLK if available) to isolate idiosyncratic takeover theta. Size hedge to neutralize market beta (~50–70% notional of ARZUM exposure). Timeframe: hold through deal resolution (1–6 months); unwind on announcement.
• Options strategy where available: buy cheap out‑of‑the‑money calls with 3–6 month tenor to lever upside while capping downside (max loss = premium). If options are illiquid, use small long equity + protective short‑dated puts to monetize time decay if bid is public and likely imminent.
• Avoid directional exposure to regional appliance suppliers until deal terms are public: instead, run a tactical short on names likely to lose procurement share if strategic consolidation occurs, but keep position small (<2% NAV) and time horizon 3–12 months given execution risk and potential counterparty FX events.